IMPAX LABORATORIES INC's ticker is IPXL and the CUSIP is 45256B101. A total of 149 filers reported holding IMPAX LABORATORIES INC in Q2 2013. The put-call ratio across all filers is 2.13 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $2,070,000 | -18.0% | 124,335 | 0.0% | 0.08% | -11.1% |
| Q3 2017 | $2,524,000 | +26.1% | 124,335 | 0.0% | 0.09% | +21.6% |
| Q2 2017 | $2,002,000 | +27.3% | 124,335 | 0.0% | 0.07% | +21.3% |
| Q1 2017 | $1,573,000 | -4.5% | 124,335 | 0.0% | 0.06% | -12.9% |
| Q4 2016 | $1,647,000 | -44.1% | 124,335 | 0.0% | 0.07% | -38.1% |
| Q3 2016 | $2,947,000 | -17.8% | 124,335 | 0.0% | 0.11% | -22.6% |
| Q2 2016 | $3,583,000 | -10.0% | 124,335 | 0.0% | 0.15% | -13.6% |
| Q1 2016 | $3,981,000 | -73.0% | 124,335 | -63.9% | 0.17% | -68.4% |
| Q4 2015 | $14,739,000 | +21.4% | 344,683 | 0.0% | 0.53% | +22.5% |
| Q3 2015 | $12,136,000 | -23.3% | 344,683 | 0.0% | 0.44% | -23.9% |
| Q2 2015 | $15,828,000 | -2.0% | 344,683 | 0.0% | 0.57% | -10.5% |
| Q1 2015 | $16,155,000 | +47.9% | 344,683 | 0.0% | 0.64% | +25.2% |
| Q4 2014 | $10,920,000 | -64.9% | 344,683 | -73.7% | 0.51% | -65.0% |
| Q3 2014 | $31,129,000 | +201.1% | 1,312,883 | +280.9% | 1.46% | +53.8% |
| Q2 2014 | $10,337,000 | +13.5% | 344,683 | 0.0% | 0.95% | +4.3% |
| Q1 2014 | $9,107,000 | +5.1% | 344,683 | 0.0% | 0.91% | 0.0% |
| Q4 2013 | $8,665,000 | +22.6% | 344,683 | 0.0% | 0.91% | +15.6% |
| Q3 2013 | $7,069,000 | +2.8% | 344,683 | 0.0% | 0.79% | -15.8% |
| Q2 2013 | $6,876,000 | – | 344,683 | – | 0.94% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 423,161 | $13,406,000 | 7.47% |
| Aravt Global | 2,300,000 | $72,864,000 | 5.43% |
| Slate Path Capital LP | 2,330,000 | $73,814,000 | 5.16% |
| Orbimed Advisors | 6,678,000 | $211,559,000 | 2.02% |
| Iguana Healthcare Management, LLC | 100,000 | $3,168,000 | 1.53% |
| Iguana Healthcare Management, LLC | 100,000 | $3,168,000 | 1.53% |
| Penn Capital Management Company, LLC | 709,045 | $22,463,000 | 0.94% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 250,000 | $7,920,000 | 0.79% |
| NEW AMSTERDAM PARTNERS LLC/NY | 276,169 | $8,749,000 | 0.76% |
| Matarin Capital Management, LLC | 52,932 | $1,676,886,000 | 0.74% |